BioticaBio runs structured, citation-backed claim testing for lean life-science funds — scientific diligence that fits the consulting line you already use for external deal help.
BioticaBio tests the claims behind life-science companies with hypothesis-driven diligence (HDDT), then publishes the evidence as authority investors, partners, and AI search can find.
Our work combines biotech domain understanding with structured evidence testing: supporting and contradicting evidence, comparator failure analysis, and investor-readiness conclusions.
Every engagement turns complex scientific evidence into an inspectable, source-linked decision artifact — and, when useful, a durable authority page.
BioticaBio provides structured claim testing for life-science funds: we run hypothesis-driven diligence on the biology, translation, comparator, and financeability claims behind a deal, then deliver a human-reviewed memo partners can bring to IC.
Diligence-Driven Authority for Life Sciences
We test the claims behind a seed or spinout deal — support, refute, and gaps — and return a citation-backed memo your IC or syndicate can actually use.